STTK - Shattuck Labs Inc
IEX Last Trade
3.59
0.100 2.786%
Share volume: 179,353
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.49
0.10
2.87%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-02-23 | 2023-05-09 | 2023-08-10 | 2023-11-09 | 2024-02-29 | 2024-05-02 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 222.943 M | 205.324 M | 177.677 M | 155.270 M | 130.457 M | 159.564 M | 146.335 M | 128.614 M | |
| Current Assets | 201.516 M | 184.584 M | 157.837 M | 136.450 M | 112.988 M | 143.220 M | 131.076 M | 114.425 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 16.402 M | 23.304 M | 22.342 M | 19.278 M | 11.914 M | 12.595 M | 16.443 M | 9.081 M | |
| Short Term Investments | 16.402 M | 23.304 M | 22.342 M | 19.278 M | 11.914 M | 12.595 M | 16.443 M | 9.081 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 185.114 M | 161.280 M | 135.495 M | 117.172 M | 101.074 M | 130.625 M | 114.633 M | 105.344 M | |
| Total Non-current Assets | 21.427 M | 20.740 M | 19.840 M | 18.820 M | 17.469 M | 16.344 M | 15.259 M | 14.189 M | |
| Property Plant Equipment | 18.242 M | 17.671 M | 16.887 M | 16.015 M | 14.796 M | 13.804 M | 12.830 M | 11.895 M | |
| Other Assets | 3.185 M | 3.069 M | 2.953 M | 2.805 M | 2.673 M | 2.540 M | 2.429 M | 2.294 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 222.943 M | 205.324 M | 177.677 M | 155.270 M | 130.457 M | 159.564 M | 146.335 M | 128.614 M | |
| Total liabilities | 23.525 M | 29.167 M | 20.023 M | 16.812 M | 17.674 M | 14.859 M | 17.522 M | 17.998 M | |
| Total current liabilities | 19.139 M | 24.965 M | 16.009 M | 12.994 M | 14.059 M | 11.453 M | 14.329 M | 15.026 M | |
| Accounts Payable | 3.036 M | 7.170 M | 5.128 M | 2.011 M | 2.016 M | 1.587 M | 2.154 M | 2.822 M | |
| Other liabilities | 0.000 | 4.202 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 4.386 M | 0.000 | 4.014 M | 3.818 M | 3.615 M | 3.406 M | 3.193 M | 2.972 M | |
| Other liabilities | 0.000 | 4.202 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 199.418 M | 176.157 M | 157.654 M | 138.458 M | 112.783 M | 144.705 M | 128.813 M | 110.616 M | |
| Common stock | 42.386 M | 42.391 M | 42.439 M | 42.468 M | 42.478 M | 43.016 M | 50.566 M | 50.791 M | |
| Retained earnings | -193.601 M | -219.012 M | -239.736 M | -261.082 M | -288.623 M | -306.310 M | -324.814 M | -346.366 M |